Mohlo by sa vám tiež páčiť

Viac informácií o knihe Antibody-Drug Conjugates

• Parametre knihy
• Anotácia kniha
• Obľúbené z iného súdka

Nákupom získate 345 bodov

Anotácia knihy

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.§

Parametre knihy

Zaradenie knihy Knihy po anglicky Technology, engineering, agriculture Industrial chemistry & manufacturing technologies Industrial chemistry

• Celý názov: Antibody-Drug Conjugates
• Podnázov: The 21st Century Magic Bullets for Cancer
• Autor: Jeffrey Wang, Wei-Chiang Shen, Jennica L. Zaro
• Jazyk: Angličtina
• Väzba: Pevná
• Počet strán: 252
• EAN: 9783319130804
• ISBN: 3319130803
• ID: 09030176
• Nakladateľ: Springer International Publishing AG
• Hmotnosť: 552 g
• Rozmery: 246 × 164 × 19 mm
• Dátum vydania: 06. March 2015

Obľúbené z iného súdka

---

---

---